Sarah Ford | February 9, 2015
Research progress report: Frizzled 9 and lung cancer chemoprevention
Every year, lung cancer leads to more deaths than any other cancer. An estimated 159,2601 Americans were expected to die from lung cancer in 2014, accounting for about 27% of all cancer deaths.
The Foundation is committed to lung cancer prevention research and currently supports five researchers studying different aspects of preventing this deadly disease. One of these researchers is Meredith Tennis, Ph.D., of the University of Colorado Denver. Her project focuses on Frizzled 9, a protein that helps to maintain normal lung tissue, as a potential biomarker2 to predict how patients may respond to the drug iloprost, a drug being used for chemoprevention.
Get Resources and Insights Straight To Your Inbox
Explore More Articles
Before the Storm: A Different Way to Think About Corporate Disaster Giving
Featured on Bright Harbor with insights from our CEO Jim Starr. Ask any corporate giving officer what their disaster response strategy looks like and you’ll…
Emergency Assistance Funds: Corporate Responsibility Begins at Home
The Hard Truth: Employee Financial Stress Directly Impacts the Workplace Approximately 2 in 5 Americans, or 37%, say they could not afford an emergency expense…
America’s Charities Named ‘Best Nonprofit To Work For’ For Sixth Consecutive Year
Washington, D.C. – April 1, 2026 – America’s Charities, a nonprofit dedicated to mobilizing the power of giving through workplace and employee engagement solutions, today…
Get Resources and Insights Straight To Your Inbox
Receive our monthly/bi-monthly newsletter filled with information about causes, nonprofit impact, and topics important for corporate social responsibility and employee engagement professionals, including disaster response, workplace giving, matching gifts, employee assistance funds, volunteering, scholarship award program management, grantmaking, and other philanthropic initiatives.
